肝肾综合征：诊断与治疗的最新进展
Hepatorenal syndrome: Update on diagnosis and treatment.
作者信息
Baraldi Olga, Valentini Chiara, Donati Gabriele, Comai Giorgia, Cuna Vania, Capelli Irene, Angelini Maria Laura, Moretti Maria Ilaria, Angeletti Andrea, Piscaglia Fabio, La Manna Gaetano
机构信息
Olga Baraldi, Chiara Valentini, Gabriele Donati, Giorgia Comai, Vania Cuna, Irene Capelli, Maria Laura Angelini, Maria Ilaria Moretti, Andrea Angeletti, Gaetano La Manna, Department of Experimental, Diagnostic, Specialty Medicine, Nephrology, Dialysis, and Renal Transplant Unit, S. Orsola University Hospital, 40138 Bologna, Italy.
出版信息
World J Nephrol. 2015 Nov 6;4(5):511-20. doi: 10.5527/wjn.v4.i5.511.
Abstract
Acute kidney injury (AKI) is a common complication in patients with end-stage liver disease and advanced cirrhosis regardless of the underlying cause. Hepatorenal syndrome (HRS), a functional form of kidney failure, is one of the many possible causes of AKI. HRS is potentially reversible but involves highly complex pathogenetic mechanisms and equally complex clinical and therapeutic management. Once HRS has developed, it has a very poor prognosis. This review focuses on the diagnostic approach to HRS and discusses the therapeutic protocols currently adopted in clinical practice.
摘要
急性肾损伤（AKI）是终末期肝病和晚期肝硬化患者常见的并发症，无论其潜在病因如何。肝肾综合征（HRS）是一种功能性肾衰竭，是AKI众多可能病因之一。HRS可能是可逆的，但涉及高度复杂的发病机制以及同样复杂的临床和治疗管理。一旦HRS发生，其预后非常差。本综述重点关注HRS的诊断方法，并讨论目前临床实践中采用的治疗方案。
相似文献
1
Hepatorenal syndrome: Update on diagnosis and treatment.肝肾综合征：诊断与治疗的最新进展
World J Nephrol. 2015 Nov 6;4(5):511-20. doi: 10.5527/wjn.v4.i5.511.
2
A Review for the Practicing Clinician: Hepatorenal Syndrome, a Form of Acute Kidney Injury, in Patients with Cirrhosis.给临床执业医师的综述：肝肾综合征——肝硬化患者急性肾损伤的一种形式
Clin Exp Gastroenterol. 2021 Oct 5;14:385-396. doi: 10.2147/CEG.S323778. eCollection 2021.
3
Improving the Management of Hepatorenal Syndrome-Acute Kidney Injury Using an Updated Guidance and a New Treatment Paradigm.使用更新的指南和新的治疗模式改善肝肾综合征-急性肾损伤的管理
Gastroenterol Hepatol (N Y). 2023 Sep;19(9):527-536.
4
Acute Kidney Injury and Hepatorenal Syndrome in Patients with Cirrhosis.肝硬化患者的急性肾损伤和肝肾综合征
J Clin Med. 2023 Dec 29;13(1):199. doi: 10.3390/jcm13010199.
5
Hepatorenal syndrome in the era of acute kidney injury.肝肾综合征在急性肾损伤时代。
Liver Int. 2018 Nov;38(11):1891-1901. doi: 10.1111/liv.13893. Epub 2018 Jun 19.
6
Epidemiology, Pathophysiology, and Management of Hepatorenal Syndrome.肝肾综合征的流行病学、病理生理学和治疗。
Semin Nephrol. 2019 Jan;39(1):17-30. doi: 10.1016/j.semnephrol.2018.10.002.
7
Acute kidney injury in acute-on-chronic liver failure: where does hepatorenal syndrome fit?急性肝衰竭中的急性肾损伤：肝肾综合征属于哪种情况？
Kidney Int. 2017 Nov;92(5):1058-1070. doi: 10.1016/j.kint.2017.04.048. Epub 2017 Aug 23.
8
Challenges in Renal Failure Treatment Before Liver Transplant.肝移植前肾衰竭治疗中的挑战。
Clin Liver Dis. 2017 May;21(2):303-319. doi: 10.1016/j.cld.2016.12.005. Epub 2017 Jan 31.
9
Terlipressin in hepatorenal syndrome: Evidence for present indications.特利加压素治疗肝肾综合征：适应证证据。
J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:109-14. doi: 10.1111/j.1440-1746.2010.06583.x.
10
Evaluation of the criteria of hepatorenal syndrome type of acute kidney injury in patients with cirrhosis admitted to ICU.对入住重症监护病房的肝硬化患者急性肾损伤肝肾综合征标准的评估。
Scand J Gastroenterol. 2018 Dec;53(12):1590-1596. doi: 10.1080/00365521.2018.1545423. Epub 2019 Jan 8.
引用本文的文献
1
Addition of a Loop Diuretic to Norepinephrine During Treatment of Hepatorenal Syndrome Type 1.在1型肝肾综合征治疗期间，在去甲肾上腺素基础上加用袢利尿剂。
Kidney Int Rep. 2024 Nov 19;10(2):466-474. doi: 10.1016/j.ekir.2024.11.013. eCollection 2025 Feb.
2
Real-world comparison of terlipressin vs. octreotide as an adjuvant treatment in the management of variceal bleeding.现实世界中特利加压素与奥曲肽作为辅助治疗用于静脉曲张出血管理的比较。
Sci Rep. 2024 Mar 20;14(1):6692. doi: 10.1038/s41598-024-56873-x.
3
A Systematic Review of the Emerging Treatment for Hepatorenal Syndrome With a Principal Focus on Terlipressin: A Recent FDA-Approved Drug.以特利加压素为主要关注点的肝肾综合征新兴治疗方法的系统评价：一种近期获美国食品药品监督管理局批准的药物
Cureus. 2023 Jul 24;15(7):e42367. doi: 10.7759/cureus.42367. eCollection 2023 Jul.
4
Adaptive Mechanisms of Renal Bile Acid Transporters in a Rat Model of Carbon Tetrachloride-Induced Liver Cirrhosis.四氯化碳诱导的大鼠肝硬化模型中肾胆汁酸转运体的适应性机制
J Clin Med. 2022 Jan 27;11(3):636. doi: 10.3390/jcm11030636.
5
Cost-Utility Analysis of Vasoconstrictors Plus Albumin in the Treatment of Thai Patients with Type 1 Hepatorenal Syndrome.血管收缩剂联合白蛋白治疗泰国1型肝肾综合征患者的成本-效用分析
Clinicoecon Outcomes Res. 2021 Jul 29;13:703-715. doi: 10.2147/CEOR.S317390. eCollection 2021.
6
Does Anemia Have a Potential Effect on Type 2 Hepatorenal Syndrome?贫血对 2 型肝肾综合征有潜在影响吗？
Can J Gastroenterol Hepatol. 2020 Dec 17;2020:1134744. doi: 10.1155/2020/1134744. eCollection 2020.
7
The emerging burden of liver disease in cystic fibrosis patients: A UK nationwide study.囊性纤维化患者中不断增加的肝脏疾病负担：一项英国全国性研究。
PLoS One. 2019 Apr 4;14(4):e0212779. doi: 10.1371/journal.pone.0212779. eCollection 2019.
8
Hepatorenal Syndrome: Physiology, Diagnosis and Management.肝肾综合征：生理学、诊断与管理
Semin Intervent Radiol. 2018 Aug;35(3):194-197. doi: 10.1055/s-0038-1660797. Epub 2018 Aug 6.
9
Artificial Liver and Renal Support System for Cynomolgus Monkeys with Surgery-Induced Acute Renal Failure: A Preclinical Study.手术诱导急性肾衰竭食蟹猴的人工肝和肾脏支持系统：一项临床前研究。
Biomed Res Int. 2018 May 24;2018:7456898. doi: 10.1155/2018/7456898. eCollection 2018.
10
Emergency Management of Spontaneous Bacterial Peritonitis - A Clinical Review.自发性细菌性腹膜炎的急诊处理——临床综述
Cureus. 2018 Mar 1;10(3):e2253. doi: 10.7759/cureus.2253.
本文引用的文献
1
Hepatorenal syndrome with cirrhotic cardiomyopathy: case report and literature review.肝肾综合征合并肝硬化心肌病：病例报告及文献综述
Case Reports Hepatol. 2015;2015:573513. doi: 10.1155/2015/573513. Epub 2015 Mar 22.
2
Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites.肝硬化患者急性肾损伤的诊断与管理：国际腹水俱乐部修订的共识建议
J Hepatol. 2015 Apr;62(4):968-74. doi: 10.1016/j.jhep.2014.12.029. Epub 2015 Jan 28.
3
Cirrhotic cardiomyopathy: review of pathophysiology and treatment.肝硬化性心肌病：病理生理学与治疗综述
Hepatol Int. 2014 Jul;8(3):308-15. doi: 10.1007/s12072-014-9531-y.
4
Renal dysfunction in patients with cirrhosis: Where do we stand?肝硬化患者的肾功能障碍：我们目前的情况如何？
World J Gastrointest Pharmacol Ther. 2014 Aug 6;5(3):156-68. doi: 10.4292/wjgpt.v5.i3.156.
5
[The hepatorenal syndrome - a review].[肝肾综合征——综述]
G Ital Nefrol. 2014 May-Jun;31(3).
6
Pathophysiology, diagnosis and clinical management of hepatorenal syndrome: from classic to new drugs.肝肾综合征的病理生理学、诊断及临床管理：从经典药物到新药
Curr Vasc Pharmacol. 2014 Jan;12(1):125-35. doi: 10.2174/157016111201140327163930.
7
Kidney injury in cirrhosis: pathophysiological and therapeutic aspects of hepatorenal syndromes.肝硬化中的肾损伤：肝肾综合征的病理生理及治疗方面
Liver Int. 2014 Sep;34(8):1153-63. doi: 10.1111/liv.12549. Epub 2014 Apr 12.
8
Urinary neutrophil gelatinase-associated lipocalin predicts kidney outcome and death in patients with cirrhosis and bacterial infections.尿中性粒细胞明胶酶相关载脂蛋白预测肝硬化合并细菌感染患者的肾脏结局和死亡。
J Hepatol. 2014 Jul;61(1):35-42. doi: 10.1016/j.jhep.2014.02.023. Epub 2014 Mar 5.
9
[Hepatorenal syndrome].[肝肾综合征]
Nephrol Ther. 2014 Feb;10(1):61-8. doi: 10.1016/j.nephro.2013.11.005. Epub 2014 Jan 1.
10
Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury.肝硬化和急性肾损伤患者的肾脏生物标志物和鉴别诊断。
Hepatology. 2014 Aug;60(2):622-32. doi: 10.1002/hep.26980. Epub 2014 Jun 26.
Zotero 插件